Search Results for 'Regenerative Medicine Institute'

A new world-class medical device research centre is to be established at NUI Galway as part of a €245 million national investment in science and technology announced this week. The funding will see five new Science Foundation Ireland research centres established around the country, with NUI Galway playing a key role in three of these.

NUI Galway researchers are part of an exciting EU-funded project looking at how stem cells from adult fat tissue could be used to activate the regeneration of cartilage. If successful, their work could lead to effective new treatments for millions of osteoarthritis sufferers. Positive, early results indicate the treatment could become a reality for patients within the next five years.

An Taoiseach Enda Kenny TD this week opened NUI Galway’s €30 million Biomedical Science Building that will bring together 300 scientists and researchers. This collaborative approach aims to build on the university’s role at the heart of Galway’s vibrant medtech sector; one of five global hubs in a market worth €95 billion annually in the EU.

A novel rare risk factor linked to mental illnesses such as schizophrenia has been identified by a multi-institutional team led by Professor Sanbing Shen of the Regenerative Medicine Institute (REMEDI) at NUI Galway.

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

Scientists at the Regenerative Medicine Institute (REMEDI) in NUI Galway have teamed up with the TCD autism research group to discover how stem cell technology can help further the understanding of autism and perhaps lead to the development of better treatments.

NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard this week.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.